Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects With Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-014-0262-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Pharmacokinetics of Lamivudine in Subjects Receiving Peritoneal Dialysis in End-Stage Renal Failure

British Journal of Clinical Pharmacology
Pharmacology
2007English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Renal Cell Carcinoma in End-Stage Renal Disease

2015English

Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects With Renal Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Transplantation in Diabetics With End-Stage Renal Disease

2011English

Managing End-Stage Renal Disease in Older Patients: A Single Centre Experience With Renal Transplantation in the Elderly

Advances in Nephrology
2014English

Uremic Frost in End-Stage Renal Disease

New England Journal of Medicine
Medicine
2018English

Thyroid Dysfunction in End Stage Renal Disease

Journal of Medical Science And Clinical Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy